Skip to main content

Table 2 Laboratory and CMR findings before and in the short-term follow-up after ALCAPA repair

From: Cardiovascular magnetic resonance assessment of ventricular function and myocardial scarring before and early after repair of anomalous left coronary artery from the pulmonary artery

Variable

Pre-repair

Post-repair

Sign. P

BNP, pg/mL (n = 7)

1349 ± 765

90 ± 66

<0.001

TNI, μg/L (n = 7)

0.34 ± 0.26

0.02 ± 0.01

0.02

Heart rate, /min

126 ± 10

122 ± 16

0.37

LVEDVi, mL/m 2

171 ± 94

68 ± 42

0.02

LVESVi, mL/m 2

139 ± 95

35 ± 45

0.02

LVSVi, mL/m 2

32 ± 11

34 ± 9

0.49

LVEF, %

22 ± 10

58 ± 19

<0.001

MM, g/m 2

91 ± 48

61 ± 30

0.04

LGE +, n (%)

2 (25)

4 (50)

0.61

LGE, % of MM

5.3 ± 5.9

5.7 ± 4.6

0.91

RVEDVi, mL/m 2

50 ± 7

48 ± 10

0.65

RVESVi, mL/m 2

20 ± 6

18 ± 5

0.60

RVSVi, mL/m 2

30 ± 8

30 ± 8

0.94

RVEF, %

59 ± 11

62 ± 7

0.65

  1. BNP, B-type natriuretic peptide; TNI, troponin I; LV, left ventricle; RV, right ventricle; i, indexed; EDV, enddiastolic volume; ESV, endsystolic volume; SV, stroke volume; MM, myocardial mass; LGE, late gadolinium enhancement; Data expressed as mean ± 1 standard deviation.